Zenas BioPharma Investor Relations Material

Zenas BioPharma Inc is a biopharmaceutical company dedicated to the development and commercialization of immunology-based therapies to treat autoimmune and rare diseases. The company focuses on leveraging its expertise in immunology to create innovative treatments that address significant unmet medical needs. Zenas BioPharma’s portfolio includes a range of product candidates designed to modulate immune system responses, aimed at improving the quality of life for patients with challenging and often underserved conditions. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the Nasdaq.